TrialAmerican journal of respiratory and critical care medicine2021

Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.

Fernando J Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.